ScripsAmerica Receives 14th State Pharmacy License

Additional Seven State Licenses Pending

New Castle, Delaware, UNITED STATES

TYSONS CORNER, Va., May 28, 2015 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB:SCRC), a leading provider of a range of specialty prescription and over the counter pharmaceuticals and medical supplies, today announced that it has received a license to distribute its pharmaceuticals in the State of Ohio. This brings the total states in which the Company is licensed to provide pharmacy services to 14. ScripsAmerica also currently has license applications pending in an additional seven states.

Bob Schneiderman, Chief Executive Officer and Founding Partner of ScripsAmerica stated, "As a key focus of our organic growth strategy, we are expanding our pharmacy business through licenses in new states. This growth will be supplemented with any additional state licenses we may acquire through the acquisition or association with other approved pharmacies, including those which are currently under Letter of Intent.  As we have added new states through both organic growth and acquisition, we have significantly increased  our addressable market from just 5 states a little more than a year ago when we first entered the industry. This builds value for shareholders."

About ScripsAmerica, Inc.

ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether a result of new information, future events or otherwise.



Contact Data